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Background: Cancer cells, even in the presence of available oxygen, have a glycolysis enhancement. The “aerobic
glycolysis” is known as the Warburg effect and it is considered one of the fundamental hallmarks of metabolic
alteration during malignant transformation. A feature of many tumors is also a change into ions equilibrium, with
particular reference to K+ intracellular concentration. Another hallmark in cancer is the reprogrammed chemotaxis
pathways in favour of tumor cell dissemination.
Results: The doubling population time of 5 mM K:D-rib treated Hs 578T (HTB-126 ® ATCC) cell line is reduce by
30% respect to the control. During the chemotactic invasion assay, the relative number of motile and invasive cells,
counted inside the FBS-AGAR spot, shows a decrease with the maintenance of the treatment reaching the 25%
after nine days. Hs 578Bst (HTB-125 ® ATCC) non-tumor cell line treated for nineteen days with 5 mM K:D-rib was
split twice as well as the control. No morphological change was visible in the treated respect to untreated cells.
Conclusions: We demonstrate that the synergic action of potassium bicarbonate and D-ribose has effect on Hs
578T cancer cell line proliferation reducing the cell cycle time. At 5 mM concentration, K:D-rib is able to modify the
tumorigenic potential of human breast cancer cell line Hs 578T, interfering in vitro with the capability of Hs 578 T
cell line to migrate under chemotactic stimuli. Despite this, K:D-rib solution, does not exhibit any appreciable
toxicity as confirmed by the proliferation assay accomplished on Hs 578Bst cell line.
Keywords: Hs 578T (HTB-126) human breast cancer cell line, Hs 578Bst (HTB-125) breast epithelial cell line,
Chemotactic invasion assay, Potassium bicarbonate, D-ribose, Doubling Population timeIntroduction
In this paper we investigate the effects of potassium
hydrogen carbonate and D-ribose in water solution
(K:D-rib) on the human breast cancer cell line - Hs
578T. We also present results on human Hs 578Bst cell
line derived from normal breast tissue peripheral to an
infiltrating ductal carcinoma, which was the source for
Hs 578T. Our previous study [1] focused on the strong
antioxidant effect of potassium ascorbate on red blood
cell oxidation [2,3] highlighted the ascorbate involve-
ment as carrier of K+ inside the cells. The role of
D-ribose in the energetic metabolism [4,5] and its in-
volvement into glycogen synthesis, as well as the import-
ance of K+ into the cell physiology, are well known [6,7].* Correspondence: simonetta.croci@unipr.it
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reproduction in any medium, provided the orIt has been found that K+ is essential to fold and to stabilize
G-quadruplex [8] with a strong relevance for telomeric
structures of telomeres [9]. Agents that stabilize G-
quadruplexes can act like anti-tumor agents [10]; so
physiological K+ concentration is demanded for not
cancer cell behaviour.
Our most recent work demonstrates that the 5 mM K:
D-rib solution slows the replication of the Hs 578T cell
line and has a cytostatic effect on canine carcinoma cell
line (A72) [11]. The effects of potassium ascorbate to-
gether with D-ribose have been investigated on Beckwith -
Wiedemann syndrome and in a case of Prader Willi
syndrome and Costello syndrome, severe syndromes
characterized both by a high oncological risk and by high
ROS concentration [12–14].
It is well known that cancer cells show an increase in
the consumption of sugars, in particular glucose, named
“Warburg Effect” [15,16]. The increase of glycolysis for
energy production is a cancer hallmark that enables thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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to anticancer therapy resistance [17–19].
Because of the hydrophilic nature of this sugar, cells
use a number of glucose transport proteins divided in
two families: the GLUT (facilitated glucose transporters)
and SGLT (sodium/glucose). The GLUT transporters
use the existing concentration gradients between the ex-
terior and the interior of the plasma membrane to facili-
tate the sugar translocation. On the contrary, the SGLT
proteins move the sugars into the cells against a concen-
tration gradient, resulting in energy cost. The SGLT1
and SGLT2 proteins are able to exchange the sugars with
Na+ through the plasma membrane to carry out this
transport [20]. Recently has been also tested [21], with
magnetic resonance imaging (MRI), the hypothesis that
the physiological and biochemical changes associated
with the proliferation of malignant tumors can cause an
increase in the total concentration of Na+ in the tissues
of patients with both benign and malignant cancer. All
these evidences demonstrate that intracellular homeosta-
sis for Na+ and K+ is no longer tightly regulated in
cancer cells and also an alteration of Na+/K+ ATPase
expression and activity has been shown in patients with
cancer [22].
It can be stated [23] that the potassium channels or ra-
ther their over expression is involved both in the in-
creased cell proliferation and in the apoptosis: a paradox
to which the answer is difficult. In this context, the
manipulation of K+ channel function and/or expression
could be a difficult option for cancer treatment.
In the case of the cell line Hs 578T there is an overex-
pression of SGLT1, these data available on Pharma-
cogenetics.UCSF.edu website and collected by Novartis
are referring to the work of Huang Y. and colleagues
[24]. This network database collects data of a project
where investigators from diverse disciplines are conduct-
ing a series of integrated studies to elucidate the
pharmacogenetics of membrane transport proteins.
Another hallmark in cancer is the reprogrammed
chemotaxis pathways in favor of tumor cell dissemin-
ation [25]. Chemotaxis is the phenomenon by which the
movement of cells is directed in response to an extracel-
lular chemical gradient and it is the result of three separ-
ate steps: chemosensing, polarization and locomotion.
Depending on the cell type and the microenvironment,
migration can involve single unattached cells or multi-
cellular groups. Tumor cells often express deregulated
profiles of chemokine receptors; therefore chemokines
and their receptors critically regulate cancer cell migra-
tion or contribute to cancer cell proliferation and sur-
vival. For example the CXCR4 chemokine receptor is
highly expressed in human breast cancer cells. In vitro
chemotaxis assays measuring the aptitude for the directed
migration, are useful in the preclinical progression ofpotential therapeutics [26]. Several assay systems currently
exist for the analysis of chemotaxis. However, most are
costly, difficult to perform, susceptible to modified condi-
tions during analysis, or difficult to multiplex.
The use of agarose, as medium through which che-
moattractants can diffuse, has provided a simple and
straightforward system to study cell motility [27].
In this work we calculate the Doubling Population
(DP) time of Hs 578T cell line treated with K:D-rib
respect to control. Then we test the effect of K:D-rib
solution on cancer chemoinvasion of Hs 578T cell line.
The study will be completed estimating a grow rate of
non-tumor breast epithelium cell line Hs 578Bst treated
with K:D-rib compared with the untreated one.
Materials and methods
Cells and culture conditions
Hs 578T adherent human breast cancer cell line was
obtained from American Type Culture Collection
(Manassas, VA, USA). Hs 578T cells were maintained
in low glucose Dulbecco’s Modified Eagle’s Medium
(Sigma Aldrich) supplemented by: 10% Fetal Bovine
Serum (Sigma Aldrich), 1% L-glutamine (Sigma Aldrich)
and 1% penicillin-streptomycin (Sigma Aldrich). Hs 578T
cell line was incubated at 37°C in humidified atmosphere
with 5% CO2.
Hs 578Bst human mammary epithelial non-tumor
cell line was purchased from American Type Culture
Collection (Manassas, VA, USA). Hs 578Bst cell line
was maintained in Hybri-Care Medium (ATCC) sup-
plemented by 1.5 g/L sodium bicarbonate (Sigma). To
make the complete growth medium, the following
components were added to the base medium: 30 ng/ml
mouse EGF (Gibco), 10% of Fetal Bovine Serum
(Lonza), 1% penicillin-streptomycin (Sigma Aldrich).
Hs 578Bst cell line was incubated at 37°C in humidified
atmosphere with 5% CO2.
Drugs and chemicals
Giemsa stain modified solution was bought from Fluka,
paraformaldehyde and D-ribose were bought from Sigma
Aldrich. KHCO3 was bought from BDH. 1 M K:D-rib
solution was obtained by mixing 0.15 g of D-ribose and
0.3 g KHCO3 in distilled water, while CO2 blown away.
The work solution was obtained by diluting the stock so-
lution with distilled water.
12 mm diameter coverslips, coated with poli-L-lisyne,
are bought from BD Italy.
Cell proliferation assay
Cell proliferation is measured with two methods.
Method 1: Hs 578T cell line was seeded at the concen-
tration of 20000 cells/ml in four-well plates; the volume
of plated cell suspension was 500 μl. The cells have been
Figure 1 Best fits with method 1 and method 2. Number of cells
(N) is plotted against incubation time with method 1 and method 2.
The linear regressions have not significantly different slopes.
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96 hours. Every 24 hours the cells were fixed by PFA at
4%, stained by Giemsa stain solution. The entire well
was pictured and all cells counted with the help of
Image J program (Plugin – Cell Counter).
Method 2: Hs 578T cell line was seeded at 4000 cells/
ml into seven 35 mm Petri dishes and treated for 14 days,
at the concentration of K:D-rib of 5 mM. For the entire
treatment duration, every 48 h one control dish and a
treated one were fixed with PFA at 4% and stained with
Giemsa stain solution. The cell counting was based on
pictures acquired field by field, along two perpendicular
axes crossing the Petri center. The counting was per-
formed with the help of Image J program (Plugin – Cell
Counter).
Splitting number
Hs 578Bst cell line was seeded at the concentration of
4000 cell/ml and the cells treated with K:D-rib solution
at the concentration of 5 mM. The duration of the ex-
periment was 19 days and the cell medium was changed
three times a week, according to our cell culture proto-
col. When the cells were approximately 90 - 100%
confluent they were split 1:2. The splitting number is re-
ported both for control cells and for 5 mM K:D-rib
treated cells.
Chemotactic invasion assay
This assay was performed following mainly the Wiggins’s
protocol [28]. 0.05 g of low melting point agarose (Sigma
Aldrich) was diluted with 10 ml PBS to obtain a solution
of 0.5% agarose. It was heated up till boiling point and
shaken to reach the complete dissolution, then removed
from heat as the agar solution was completely melted.
90 μl of melted agarose were dropped into 1.5 ml tube,
supplied with 10 μl of FBS (AGAR + FBS), as chemoac-
trant enhancer. In another tube 90 μl of agar alone
(AGAR) were dropped. 10 μl of each agarose solution
were pipetted on two 12 mm diameter coverslips coated
with poly-L-lysine and placed in a 35 mm Petri dish.
After that, the dishes were left 30 minutes waiting for
AGAR cooling and for the right spot texture. Before the
chemotactic invasion assay the cells were pre-treated
with 5 mM K:D-rib solution for different time: 3, 5 and
7 days. At the end of each pre-treated time, 20000 cells/
ml were plated into a dish containing the two agar spots
and 5 mM K:D-rib solution. Another sample has be
done using 5 day pre-treated cells, plated into a dish
containing the two agar spots. In this case the treatment
was suspended during the chemotactic assay. The dur-
ation assay was 48 h and at the end, each AGAR spot
was photographed. For each spot the number of inner
cells was counted and divided by the perimeter of each
spot. The perimeter was calculated using Image J program.Cells not fully inside the spot were not counted. The same
was done in case of control (cells without treatment) and
the number of treated cells were normalized to the control.
Statistical analysis
Data of cell proliferation assay are analysed with t-test to
compare method 1 and method 2. In details, the slope of
linear regression of control data, obtained with method
1, is compared with the slope of linear regression of con-
trol data, obtained with method 2, using t-test for
coupled data. Then the slope of linear regression of con-
trol data is compared with the slope of linear regression
of treated data (both obtained with method 2) using, as
well, t-test for coupled data.
Results
Doubling Population (DP) time on Hs 578 T
Two different counting methods on control Hs 578T
cells (without treatment), have been used to establish a
consistent way to calculate the DP time. Because it is
well known that the cancer cells grow exponentially [24]
in vitro, the number of cells was fitted with the following
equation,
In2 Nð Þ ¼ td þ In2 N0ð Þ ð1Þ
where N is the number of cells at t time, N0 (method
1) is the seeded cell number and d is the DP time.
In case method 2, 4000 cells/ml were seeded in a
35 mm Petri dishes. This time only the cells lying on
two perpendicular axes crossing the Petri centre were
counted. The experiment was extended to 14 days. In
this case using equation 1 the obtained N0 value is pro-
portional but not equal to the number of seeded cells.
The d value stills the DP time.
In Figure 1 are reported the best fits of data obtained
using the two reported methods. In particular in case of
method 1 the best-fit procedure gives N0 = 11036 ± 153
cells and d = 40 ± 5 h. With this method we obtained a
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(~10000).
With method 2 we calculate the DP time that results
d = 44 ± 1 h. We perform a t-test to compare the slopes
of linear regression of the data obtained with method 1
and method 2. The t-test gives a P = 0.63, therefore since
the slopes are not significantly different, it is also pos-
sible to calculate a slope for all data. The pooled slope
equals 0.0223 and consequently the control DP time is
dC = 44 ± 5 h.
Since the two methods are not significantly different
to calculate the DP time, we decided to use the method
2 to calculate the DP time of the cells treated (T) with
5 mM K:D-rib. As reported in Figure 2 the linear regres-
sion of T data has a slope that is different to that one of
the control (C) data: the DP time results to be dT = 59 ±
2 h. To compare the slopes, we perform a t-test of the
two data sets, resulting a value t = 3.114 (P = 0,0256) > tc
= 2,571 (P = 0.05). We can conclude that the difference
between the slopes, and therefore the difference between
the DP times of control and treated cells, is significant.
Chemotactic invasion assay
In Figure 3(A) is depicted the AGAR - FBS spot invaded
by cancer cells, because of chemoactrant properties of
Fetal Bovine Serum. Herein the high cell tumorigenic
potential is shown. Hs 578T cell line comes into the FBS
- AGAR spot from every point of spot edge. The white
line draws the inner border of the spot.
In Figure 3(C) is reported the negative control of che-
moinvasion assay: cells do not enter into the AGAR spot
FBS free. AGAR alone has not the chemoactrant properties
showed by AGAR - FBS. The cells reach the spot edge, they
touch it but they are not able to get into the spot.
The treatment reported in Figure 3(D), relative to five
days with 5 mM K:D-rib, consists on three pre-treatment
days and two treatment days during the chemotactic assay.
The cells come into the AGAR - FBS spot from any sidesFigure 2 Best fits of control and treated cells. Number cells (N)
as function of incubation time in case of control (blue) and 5 mM
K-D:rib treated cells (red). The linear regressions have significant
different slopes.of the spot edge, as shown in the control test. The morph-
ology has not been modified respect to the control.
Figure 3(E) illustrates migration and invasion after
seven days of the treatment (five days of pre-treatment
plus two treatment days during the chemotactic assay).
The cell morphology looks like the control one. The Hs
578T cell line treated invades the AGAR - FBS spot from
whole spot perimeter as described in the control. Fig-
ure 3(F) shows how the cells react without 5 mM K:D-
rib during assay. The morphology is like to the control.
This result is compared to that one get from 7 days of
the K:D-rib 5 mM treatment (5 treatment days plus two
assayed days with treatment).
Figure 3(G) highlights the effect of the longest treatment
with 5 mM K:D-rib. In case of control, Figure 3(A), the
maximum distance from the border reached by the cells
along radius is 0,14 mm while in case of 9-day treatment;
all the cells stay nearby the border, Figure 3(G). Only in
the case reported in the Figure 3(H), the cells reach the
distance of 0,11 mm. Although the treatment of the Hs
578 T cell line affects the chemoinvasion potential, the cell
morphology looks like the control.
In the Figure 4 is plotted the relative number of motile
and invasive cells counted inside the FBS-AGAR spots
normalized to the control cell number and divided by
the perimeter of the spot to avoid errors due to the dif-
ferent spot dimension.
The five day experiment (three treatment days plus 48
hours of treatment assay) and the seven day experiment
(five treatment days plus 48 hours of treatment assay)
show a relative cell number decrease with the mainten-
ance of the treatment, compared with the control. The
relative cell number of the nine day experiment (seven
treatment days plus 48 hours of assay treatment) de-
creased to 25%.
When the Hs 578T cell line is treated for seven days
and the chemotactic invasion assay is perform without
treatment (red column), the relative cell number is
greater than the nine day treatment (seven treatment
days plus 48 hours of treatment assay). The relative cell
number is the same (~55%) reached after the five days
of treatment plus two treatment days during the chemo-
tactic assay.
K:D-rib affect Hs 578Bst proliferation
Hs 578Bst cell line (human epithelial breast cancer) has
been treated for nineteen days with K:D-rib water solu-
tion at the concentration of 5 mM. Both control and
treated cells were split twice during the experiment.
Figure 5(A) is relative to the control and in Figure 5(B)
to the K:D-rib treated cells at twelfth day of the experi-
ment. Analysing the morphology of the treated and un-
treated cells, it is clear that K:D-rib treatment do not
change the morphology of Hs 578Bst cell line. Then,
Figure 3 Chemotactic invasion assay with AGAR - FBS spot. On the left (A), Hs 578T control cells into agar spot supplied with Fetal Bovine
Serum (FBS). On the right (B), is reported the maximum distance from the border (d = 0.140 mm) reached by control cells, in the spot radius
direction. On the left (C) Hs 578T control cells on the border of AGAR spot without FBS. On the right (D) are reported Hs 578T cells relative to
five days of 5 mM K:D-rib treatment: three pre-treatment days and two treatment days during the chemotactic assay. On the left (E) are reported
Hs 578T cells relative to seven days of 5 mM K:D-rib treatment: five pre-treatment days and two treatment days during the chemotactic assay. On
the right (F) are reported Hs 578T cells relative to the seven day K:D-rib treatment: seven pre-treatment days and two days of chemotactic assay
without treatment. On the left (G) are reported Hs 578T cells relative to nine days of 5 mM K:D-rib treatment: seven pre-treatment days and two
treatment days during the chemotactic assay. On the right (H), is reported the maximum distance from the border (d = 0.11 mm) reached by
cells, in the spot radius direction. The white line delimits the edge of the agar - FBS spot.
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assay the effects of each K:D-rib component. Hs 578Bst
cell line are treated with 5 mM of D-ribose, 5 mM of
KHCO3 and 5 mM K:D-rib solution. The experiment
duration was nineteen days, to compare it to previous
Hs 578Bst cell line experiment. Not treated Hs 578Bst
cell line has been split twice in each proliferation experi-
ment as well as the treated. The treated cell with eachseparated components of K:D-rib solution do not display
any morphological change.
Discussion and conclusions
Doubling Population (DP) time on Hs 578T
The assumption that the tumor cells grow exponentially
is widely accepted [28] for early steady and for in vitro sys-
tem. Because this hypothesis we calculate the duplication
Figure 4 Relative Hs 578T cell number. Cells without treatment (ctrl) and cells after 5, 7, 9 days of treatment with 5 mM K:D-rib. 5, 7, 9 days of
treatment include 48 hours of chemotactic invasion assay with treatment. The last column represents the relative cell number after 7 days of
treatment but without treatment during 48 h of chemotactic invasion assay.
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also well known that when these conditions are not fully
satisfied, for example in vivo or in cell colony growing
in vitro, the equation (1) cannot be used anymore and other
method to analyse the growth, such as fractal scaling tech-
nique, has to be used [29,30].
Fulfilling the above conditions, the DP time of treated
cells is 59 h respect to 44 h of the control. From these
results we demonstrate that the synergic action of potas-
sium bicarbonate and D-ribose has effect on Hs 578T
cancer cell line proliferation reducing the cell cycle time
of 5 mM K:D-rib treated cells by 30% respect to the
control.
Chemotactic invasion assay
In order to demonstrate the effects of K:D-rib water solu-
tion at the concentration of 5 mM and how it can modify
the tumorigenic potential of human breast cancer cell lineFigure 5 Hs 578Bst cells. On the left (A), Hs 578Bst control cells at the da
with 5 mM K:D-rib.Hs 578T, we performed the chemotactic invasion assay.
This assay gives the information about the invasive poten-
tial of cancer cells under chemotactic stimuli provide by
FBS (fetal bovine serum). Because Hs 578T cells interact
with the AGAR – FBS spot and invade it, this assay fits to-
gether migration and invasion, two important hallmarks of
the cancer cells.
Hs 578T cell line is able to migrate across the coverslip
toward the FBS – agar spot and to invade it within
48 hours (Figure 3 - A) in any directions not privileging
anyone respect to other. We can assume that the spot
gets an equal physical resistance to cell invasion. On the
contrary the AGAR spot without FBS does not exert the
same stimuli to Hs 578 T cell line, which accumulate on
the spot edge and do not get into the spot (Figure 3 - C).
We have investigated how K:D-rib solution, at the
concentration of 5 mM modifies the cancer features
mentioned above. In the Figure 4 the relative cell numbery 12th; on the right (B) Hs 578Bst cells at day 12th of treatment
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of treatment. After nine days of treatment the cells are al-
most not able to invade the AGAR – FBS spot, demon-
strating that tumorigenic potential highly decreases at the
ninth day of the treatment. The difference of relative cell
number between the seven days of the treatment and the
nine days one is the highest, around 30%. These results
show that 5 mM K:D-rib interferes in vitro with the cap-
ability of Hs 578T cell line to migrate under chemotactic
stimuli, to reach the stimuli source and to invade a differ-
ent texture structure.
After 7 days of treatment, the chemotactic invasion
assay was made both prolonging and suspending the
treatment during the assay. Hs 578T cell line pre-
treated for seven days and assayed for 48 h without
treatment shows comparable values with those ob-
tained from the fifth day of the pre-treatment and
assayed for 48 h with treatment.
These results drive us to believe the K:D-rib solution
as modifier of tumorigenic marks even if it is employed
during the assay.
Another aspect that it should be considered is the
tracks inside AGAR-FBS spot. The cancer cells after
9 days of treatment show a shorter path, that demonstrates
difficulties for migration and invasion, two important can-
cer cell hallmarks changed by K:D-rib treatment.
Hs 578Bst cell line
The effects of K:D-rib solution on cell growth rate are
detectable counting the splitting number during the ex-
perimental extent. This type proliferation assessment
has been used, because of the unreliability of the broadly
used metabolic assays as MTT assay. These results re-
cently published, prove the interaction of MTT salt
(tetrazolium bromide) with the K:D-rib solution and the
solution reduces MTT salt to formazan as the ascorbic
acid does [12,27]. The splitting number is a useful cell
culture laboratory practice, which gives information
about cells trend growth. We have used this tool to as-
sess the K:D-rib effects on proliferation of non-tumor
Hs 578Bst cell line. Hs 578Bst cells treated for 19 days,
with K:D-rib solution at the concentration of 5 mM, do
not show toxicity and or noteworthy cell proliferation
slowing rate. The splitting number of the treated and
untreated cells is the same. Comparing the effects of K:
D-rib solution on proliferation of Hs 578T cell line
(human breast cancer) and Hs 578Bst cell line (human
breast epithelial) is evident that the magnitude effect is
cell type specific. K:D-rib dampens the Hs 578T cell line
proliferation rate already within the first treatment week.
Treated Hs 578Bst cells do not show any duplication cell
rate slowing during the treatment period.
The data of the chemoinvasion assay and the results from
the cancer and not cancer cell proliferation demonstratethat the 5 mM K:D-rib water solution is a powerful inhibi-
tor of cancer potential and a strong antiproliferative agent.
Despite this, K:D-rib solution, does not exhibit any ap-
preciable toxicity as confirmed by the proliferation
assay accomplished on Hs 578Bst cell line.
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